Key takeaways:
Triptans and calcitonin gene-related peptide (CGRP) antagonists are prescription-only migraine medications. Triptans are common first-choice treatments, while CGRP antagonists are usually considered when you need another option.
Triptans and CGRP antagonists work in different ways. They also have different side effects and dosage forms available. Your healthcare provider can help you choose which migraine medication is the right fit for you.
Triptans have been around for longer, and they’re available as lower-cost generics. CGRP antagonists only come as brand-name products.
Living with migraines can be tough. They’re unpredictable and disrupt your daily life. Thankfully, there are many migraine treatments that can offer relief.
If you have migraines, you’ve likely looked into some of these treatment options. Triptans and calcitonin gene-related peptide (CGRP) antagonists are two popular kinds of migraine medications. Triptans have been around since 1992, and the FDA approved the first CGRP antagonist in 2018.
So, how do triptans compare to CGRP antagonists for migraines? Below, we’ll cover five key differences to help you and your healthcare provider decide which medication might be the right fit for you.
Triptans and CGRP antagonists have unique mechanisms of action. Meaning, they fight your migraines using different strategies.
During a migraine attack, blood vessels in the brain can swell up, leading to pain and other symptoms. Triptans work by binding to specific receptors (chemical binding sites) throughout your body to reduce blood vessel swelling. What’s more, triptans block pain signals coming from your nerves.
CGRP antagonists work by blocking CGRP from doing its job. CGRP is a neurotransmitter (chemical messenger) that can trigger migraines. Studies show that people who experience migraines have higher levels of CGRP in their body.
Triptans and CGRP antagonists are available as oral tablets. But they come in many other dosage forms, too. This gives you flexibility in how to manage your migraines. Below, we’ll list the available migraine medications and their dosage forms.
Here are the available triptans and their dosage forms.
Triptan | Brand or generic | Dosage form(s) |
---|---|---|
Sumatriptan | Generic sumatriptan | Oral tablet Nasal spray Under-the-skin injection |
Imitrex | Oral tablet Nasal spray Under-the-skin injection |
|
Zembrace SymTouch | Under-the-skin injection | |
Tosymra | Nasal spray | |
Treximet (sumatriptan and naproxen) | Oral tablet | |
Onzetra Xsail | Nasal powder | |
Rizatriptan | Generic rizatriptan | Oral tablet Orally disintegrating tablet |
Maxalt | Oral tablet | |
Maxalt-MLT | Orally disintegrating tablet | |
Rizafilm | Orally dissolving film | |
Zolmitriptan | Generic zolmitriptan | Oral tablet Orally disintegrating tablet Nasal spray |
Zomig | Oral tablet Nasal spray |
|
Eletriptan | Generic eletriptan | Oral tablet |
Relpax | Oral tablet | |
Naratriptan | Generic naratriptan | Oral tablet |
Frovatriptan | Generic frovatriptan | Oral tablet |
Frova | Oral tablet | |
Almotriptan | Generic almotriptan | Oral tablet |
All CGRP antagonists are currently available as brand-name-only products. Here are the available CGRP antagonists and their dosage forms.
Nurtec ODT (rimegepant), an orally disintegrating tablet
Ubrelvy (ubrogepant), an oral tablet
Qulipta (atogepant), an oral tablet
Zavzpret (zavegepant), a nasal spray
Emgality (galcanezumab-gnlm), an under-the-skin injection
Aimovig (erenumab-aooe), an under-the-skin injection
Ajovy (fremanezumab-vfrm), an under-the-skin injection
Vyepti (eptinezumab-jjmr), an intravenous (IV) infusion
Studies suggest that triptans may be more effective than CGRP antagonists for treating migraines. But triptans are only FDA approved for the treatment of migraines. They can’t prevent them. And they’re most effective when they’re taken as soon as your migraine symptoms start. They may not work as well if you wait to take a dose until your migraine symptoms are fully underway.
What’s more, due to side effect risks, you shouldn’t take triptans more than 2 days per week. Talk with your healthcare provider if you find yourself needing more migraine relief. You may need to try another medication to prevent migraines.
CGRP antagonists can be used for migraine treatment and/or prevention. Here’s a breakdown:
Medication | Treatment | Prevention |
Nurtec ODT | X | X |
Ubrelvy | X | |
Qulipta | X | |
Zavzpret | X | |
Emgality | X | X |
Aimovig | X | |
Ajovy | X | |
Vyepti | X |
Keep in mind: Every CGRP antagonist is FDA approved to treat or prevent a specific type of migraine. Your healthcare provider can help you choose the right CGRP antagonist based on your symptoms.
Like all medications, triptans and CGRP antagonists can cause side effects. But studies show that CGRP antagonists generally cause fewer side effects than triptans.
Common triptan side effects include:
Nausea
Dizziness
Tingling sensations on the skin
Chest tightness
Flushing (facial redness)
Some of the most common CGRP antagonist side effects include:
Injection site reactions (itching, redness, pain) for injectable medications
Nausea
Constipation
Fatigue
Good to know: Side effects for both triptans and CGRP antagonists vary by medication and dosage form. Discuss the risks of a specific medication with your healthcare provider or pharmacist.
Triptans can constrict blood vessels throughout your entire body. This can increase your risk of serious heart-related problems, including heart attack and stroke. For this reason, people with heart problems shouldn’t take triptans.
Some CGRP antagonists are monoclonal antibodies that are injected into your body. Monoclonal antibodies are human-made proteins that mimic parts of your immune system. CGRP antagonists could trigger your immune system and cause an allergic reaction. These reactions can range from mild to life-threatening.
Although these serious side effects are rare, it’s important to be aware of them.
All triptans and CGRP antagonists are prescription-only medications. But triptans are generally more affordable. Over time, lower-cost, generic triptans have become available.
It’s also important to note that many health insurance plans require a prior authorization (PA) for CGRP antagonists. With a PA, your healthcare provider must submit additional paperwork to your insurance provider before they’ll cover the cost of your medication. Since there are less expensive medications on the market, such as triptans, insurance companies may ask you to try those options first.
What’s more, due to side effect concerns, insurance companies often limit how many triptan doses you can receive in a month. For example, your insurance company may only cover 9 tablets per month. Your provider may need to fill out a PA form if you need more than their set monthly limit.
Insurance exceptions like this can lead to delays with picking up your prescription.
According to the American Headache Society, triptans are a first-choice option for treating moderate-to-severe migraines. CGRP antagonists are more of a second choice option. But many CGRP antagonists work especially well for migraine prevention.
In certain situations, your healthcare provider may recommend one medication type over the other.
You should avoid triptans if you have a history of heart-related health conditions, including:
High blood pressure that isn’t well controlled
Previous heart attack
Previous stroke
CGRP antagonists may be a better choice for people with these conditions. In fact, studies suggest that CGRP antagonists may be beneficial in some cardiovascular diseases.
Several medications and supplements can interfere with how your body processes triptans or CGRP antagonists. Your healthcare provider may recommend adjusting your medication dosages or avoiding certain medications altogether.
For instance, triptans should be avoided with medications that raise serotonin levels. This interaction can cause a rare but serious condition called serotonin syndrome. Symptoms of serotonin syndrome can include sweating, confusion, and involuntary body movements. Examples of medications that affect serotonin include:
Selective serotonin reuptake inhibitors (SSRIs) such as sertraline (Zoloft)
Serotonin and norepinephrine reuptake inhibitors (SNRIs) such as duloxetine (Cymbalta)
CGRP antagonists have some interactions, too. For instance, Qulipta and Nurtec ODT are broken down by certain enzymes (proteins) in your liver. Ketoconazole, phenytoin (Phenytek, Dilantin), and clarithromycin (Biaxin XL) can interfere with these enzymes and cause problems.
Keep in mind: All medications have their own unique interactions. Be sure to discuss your entire medication list with your pharmacist.
If you have moderate-to-severe kidney or liver problems, CGRP antagonists may be a better option for migraine relief. This is because people with severe kidney or liver problems shouldn’t take triptans. They haven’t been very well studied in these populations.
No. It’s not recommended to combine triptans with CGRP antagonists. If you’re taking either medication and you feel like your migraines aren’t adequately controlled, reach out to your provider. They can make recommendations to shake up your medication routine.
Triptans and calcitonin gene-related peptide (CGRP) antagonists are both effective for migraine relief. And they each have several dosage forms to choose from. But triptans and CGRP antagonists work in unique ways, and they have different side effects to know about. What’s more, triptans can only be used for migraine treatment, while CGRP antagonists can treat and prevent migraines.
If you’re interested in learning more about triptans versus CGRP antagonists, talk to your healthcare provider. They can help you determine which medication is best for you based on your needs, symptoms, and preferences.
Ailani, J., et al. (2021). The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. Headache.
Cohen, J. M., et al. (2021). Immunogenicity of biologic therapies for migraine: A review of current evidence. The Journal of Headache and Pain.
Linda, A. H., et al. (2021). Drug interactions and risks associated with the use of triptans, ditans and monoclonal antibodies in migraine. Current Opinion in Neurology.
Musial, L., et al. (2023). Prior authorization requirements for calcitonin gene-related peptide antagonists. The American Journal of Managed Care.
Nicolas, S., et al. (2023). Triptans. StatPearls.
Rashid, A., et al. (2023). Calcitonin gene-related peptide receptor. StatPearls.
Soldin, O. P., et al. (2013). Triptans in pregnancy. Therapeutic Drug Monitoring.
Tepper, S. J. (2018). History and review of anti-calcitonin gene-related peptide (CGRP) therapies: From translational research to treatment. Headache.
Yang, C. P., et al. (2021). Comparison of new pharmacologic agents with triptans for treatment of migraine. Journal of the American Medical Association Network Open.